Centers for Disease Control and Prevention CDC Home Search Health Topics A-Z

phppo image
U.S. Department of Health & Human Services logo

hyperlink pointer Home
hyperlink pointer General Links
hyperlink pointer Emergency Contacts
Agents/Diseases
hyperlink pointer Biological Agents
hyperlink pointer Chemical Agents
CDC's Program
hyperlink pointer Epi/Surveillance
hyperlink pointer Info/Communications
hyperlink pointer Laboratory
hyperlink pointer Legal/Ethical Issues
hyperlink pointer Planning Guidance
hyperlink pointer State/Local Efforts
hyperlink pointer Training
Press Releases
hyperlink pointer Media/Health Comm
En Español
hyperlink pointer Página principal de Terrorismo Biológico
 
 
Public Inquiries
(404) 639-3534
(800) 311-3435

Centers for Disease Control and Prevention
1600 Clifton Rd.
Atlanta, GA 30333
U.S.A
(404) 639-3311

FirstGov
General Clinical Public Health Laboratory

ANTHRAX

 CDC Health Alerts, Advisories & Updates
CDC Update: Confirmed Cases of Anthrax, Nov. 2, 2001
Updated Information About How to Recognize and Handle a Suspicious Package or Envelope, Oct. 31, 2001
Media on Demand (archived webcast) - Anthrax: What Every Clinician Should Know Part II, Thursday November 1st, 2001 1:30-3:00 PM EST
CDC Update: Statement regarding postal and other mailroom facilities in the Metropolitan Washington DC area, Oct. 27, 2001
All Clinical Updates       All Updates
 Screening & Diagnosis of Anthrax

What are the signs and symptoms of Cutaneous, Inhalational & Gastrointestinal anthrax?

  
Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax (Nov 2, '01)  
Microbiologic image of B. anthracis  
Images of Cutaneous Anthrax  
Radiology of Inhalational Anthrax  
 Treatment Guidelines for Anthrax
Inhalational anthrax treatment protocol (from MMWR, Oct. 26, 2001)  
Cutaneous anthrax treatment protocol (from MMWR, Oct. 26, 2001)  

Postexposure Prophylaxis For Prevention Of Inhalational Anthrax

  
Use of doxycycline for prevention of B. anthracis infection among populations at risk may be preferable [to use of ciprofloxacin], Nov. 2, 2001  

Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis, Nov. 2, 2001

  

Side effects of treatment with Ciprofloxacin

  

For clinician distribution: Patient Information on Ciprofloxacin

  

For clinician distribution: Patient Information on Doxycycline

  
 Frequently Asked Questions

What are the signs and symptoms of anthrax?

  

How is anthrax diagnosed?

 
Show All Frequently Asked Question's
News & Articles



None at this time

In the Spotlight
In the Spotlight



NEW Treatment Guidelines for Anthrax


Related Links

"Anthrax: What Every Clinician Should Know, Part II"
Co-Sponsored by the National Medical Association, CDC, and Local Public Health, Originating from Howard University
Thurs, Nov 1, 2001

Video/Satellite archive

All Related Sites

 
In general all information presented in these pages and all items available for download are for public use. However, you may encounter some pages that require a login password and id. If this is the case you may assume that information presented and items available for download therein are for your authorized access only and not for redistribution by you unless you are otherwise informed.

Content related questions should be directed to: Content Administrator
Site related questions should be directed to: Webmaster
This page last reviewed: October 26th, 2001

**Adobe Acrobat Reader 5.0 may be required for large documents**